47
Participants
Start Date
April 28, 2022
Primary Completion Date
September 12, 2023
Study Completion Date
October 13, 2023
OCE-205
The drug product, OCE-205, is a sterile solution to be used for intravenous infusion.
Placebo
Placebo to match OCE-205 is a sterile solution to be used for intravenous infusion.
New York-Presbyterian Hospital, New York
MedStar Georgetown University Hospital, Washington D.C.
University of Maryland Medical Center, Baltimore
McGuire VA Medical Center, Richmond
Virginia Commonwealth University Health System, Richmond
Medical University of South Carolina, Charleston
Piedmont Atlanta Hospital, Atlanta
Tampa General Medical Group, Tampa
University of Cincinnati Medical Center, Cincinnati
Indiana University Hospital, Indianapolis
M Health Fairview University of Minnesota Medical Center, Minneapolis
Mayo Clinic, Rochester
Northwestern Medicine, Chicago
University of Missouri, Columbia
Baylor University, Dallas
CHI St Luke's Health Baylor College of Medicine Medical Center, Houston
Mayo Clinic - Phoenix, Phoenix
Keck Medical Center of USC, Los Angeles
University of California, San Francisco Liver Clinic, San Francisco
Stanford Hospital, Stanford
Massachusetts General Hospital, Boston
Rutgers New Jersey Medical School, Newark
Toronto General Hospital, Toronto
Lead Sponsor
Ocelot Bio, Inc
INDUSTRY